Priovant Therapeutics
NC - DurhamBiotechnology
Focus: Priovant Therapeutics is a Durham, NC-based biotechnology company focused on autoimmune therapies, specifically developing oral immunomodulators for rare and orphan inflammatory diseases.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
3-42 this month
Contracting — net -42 jobs in 30d
1 added, 43 removed. Active reduction in progress.
Should You Work at Priovant Therapeutics?
AI assessmentBest suited for early-career or mission-driven professionals willing to accept financial uncertainty in exchange for rare-disease therapeutic impact and clinical development breadth.
Why Work Here
- Lead a focused pipeline of 6 clinical trials in high-need immunology indications with multiple Phase 3 programs advancing toward potential approvals.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Oral Brepocitinib
Cutaneous SarcoidosisClinical Trials (2)
NCT07532603A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Phase 2/3Help build intelligence for Priovant Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.